Savya Center for Advanced Neuromodulation
Targeted Relief. Total Stability.
Precision DRG stimulation offers consistent, pinpoint relief that remains stable, even with movement.
Beyond Side Effects. Pure Relief.
Targeted Drug Delivery systems deliver potent medication where it's needed most, minimizing systemic side effects.
Stop Managing Pain. Start Living.
Pioneering Neuromodulation Solutions when medications and previous surgeries fall short.
The Future of Pain Relief is Programmable.
Customized Neurostimulation options give you back control, reducing dependence on daily medication.
Ready to take the next step?
Personalized solutions through world-class expertise.
What is Advanced Neuromodulation?
Advanced Neuromodulation is a class of cutting-edge therapies designed to specifically alter nerve activity by delivering targeted electrical or pharmaceutical agents to the nervous system. These treatments focus on reducing chronic pain by interrupting pain signals before they reach the brain. Crucially, neuromodulation procedures are both **reversible** and **non-destructive**, offering a powerful alternative when traditional treatments—including oral medications, physical therapy, and less-invasive surgeries—have failed.
Addressing Chronic Pain
- For patients who have exhausted conservative pain relief options.
- Targeting neuropathic and complex mixed pain syndromes.
- Focusing on functionality and reduced reliance on systemic medication.
Meet Dr. Hemant Kalia: Center Director & Thought Leader
Dr. Hemant Kalia, MD, MPH, FIPP, FAAPMR
Dr. Hemant Kalia is a nationally recognized leader in Advanced Neuromodulation. His commitment to research ensures every patient benefits from cutting-edge, evidence-based care.
Institutional Experience
Cumulative Procedures Since 2018
Advanced Neuromodulation Volume (All Therapies)
SCS / DRG Implants
IDDS / TDD Pumps
Our Comprehensive Spectrum of Solutions
Spinal Cord Stimulation (SCS)
Broad spectrum solution for intractable neuropathic pain, involving an electrical field to mask pain signals. Requires an initial trial period.
Dorsal Root Ganglion (DRG)
Highly specialized for localized pain, especially Complex Regional Pain Syndrome (CRPS). Offers superior stability against patient movement.
Learn More →
Peripheral Nerve Stimulation (PNS)
Minimally invasive, targeted relief for pain originating from peripheral nerves in the extremities, occipital nerves, or post-amputation pain.
Learn More →
Targeted Drug Delivery (IDDS/TDD)
A non-electrical option delivering medication directly to the spinal fluid, minimizing systemic side effects. Ideal for cancer pain or spasticity.
Learn More →
5.1. Spinal Cord Stimulation (SCS)
SCS is an established system where mild electrical impulses are delivered to the epidural space, effectively replacing or masking chronic neuropathic pain sensations.
-
- Mechanism: Electrical impulses near the spinal cord interrupt pain signals.
- Indications: Failed Back Surgery Syndrome (FBSS), chronic intractable pain, certain CNS pain.
- Key Benefit: Patient Control via external programmer to adjust pulse parameters.
- Process: Mandatory initial temporary trial period before permanent implantation.
5.2. Dorsal Root Ganglion (DRG) Stimulation
DRG stimulation offers precision targeting for highly localized, debilitating neuropathic pain conditions, such as Complex Regional Pain Syndrome (CRPS) Type II.
-
- Mechanism: Leads placed near the dorsal root ganglion, which is stabilized by bone.
- USP: This anatomical stability ensures precise targeting and consistent relief, unlike standard SCS leads which can shift with movement.
- Primary Use: Uniquely effective for localized pain and complex conditions like CRPS
5.3. Peripheral Nerve Stimulation (PNS)
PNS targets nerves outside the central nervous system. It is a highly minimally invasive, safe, and often same-day procedure, supported by Level 1 evidence for efficacy.
-
- Indications: Chronic back pain, chronic neuropathic pain of the extremities, occipital nerve-related headaches, and post-amputation pain.
- Added Benefit: Evidence supports its use in reducing postoperative pain and subsequent opioid reliance in surgical settings.
- Candidacy: For patients whose pain originates from peripheral neuropathy and wish to avoid major surgery.
5.4. Intrathecal Drug Delivery (IDDS/TDD)
IDDS is a non-electrical option that delivers medication directly into the cerebrospinal fluid (intrathecally), ensuring high local concentrations with minimal systemic absorption.
-
- Cancer Pain: For intractable pain refractory to conventional management due to intolerable systemic side effects.
- Spasticity: Commonly used to deliver Baclofen to manage severe spasticity (e.g., SCI, MS, cerebral palsy).
- Core Benefit: Drastically reduced systemic drug adverse effects and lower required drug dosage.
Pioneering Excellence: Dr. Kalia’s Thought Leadership
National Consensus Guidelines
- The American Society of Pain and Neuroscience (ASPN) evidence-based clinical guideline of interventional treatments for low back pain
- Consensus guidelines from the American Society of Pain and Neuroscience for the use of 60-day peripheral nerve stimulation therapy. A NEURON Living Guideline Project
- An evidence-based consensus for the use of neurostimulation for the treatment of non-surgical low back pain: the NEURON group
- Consensus Guidelines for the Use of Peripheral Nerve Stimulation in the Treatment of Chronic Pain and Neurological Diseases: A Neuron Project from the American Society of Pain …
- Device Evaluation, Treatment, and Explantation Recommendations (DETER): Review and Best Practices for Managing Neuromodulation Device Infections
- Guidelines From the American Society of Pain and Neuroscience for Using Artificial Intelligence in Interventional Spine and Nerve Treatment
- The American Society of Pain and Neuroscience (ASPN) Evidence-Based Consensus Recommendations on Programming and Coding Implantable Spinal Cord Stimulation Devices for …
Foundational & Clinical Contributions
- A comprehensive practice guideline for magnetic resonance imaging compatibility in implanted neuromodulation devices\
- A review of the bioelectronic implications of stimulation of the peripheral nervous system for chronic pain conditions
- Application of the novel Nalu™ Neurostimulation System for peripheral nerve stimulation
- Successfully Implanted DCS and PfNS Hybrid System for Axial Low Back Pain (10677)
- DRG (Dorsal Root Ganglion): A Novel Neurostimulation Site for Spasticity Management: ID: 14486
- ID: 16203 Brachial Plexus Stimulation for Refractory Neuropathic Upper Limb Pain in a Traumatic Brain Injury Patient
- Real-world healthcare utilization and costs of peripheral nerve stimulation with a micro-IPG system
- Educational curriculum for peripheral nerve stimulation developed by the North American Neuromodulation Society
Mandatory Legal and Ethical Disclosures
Institutional Experience data reflects the cumulative number of advanced neuromodulation procedures performed by the Savya Center for Advanced Neuromodulation since 2018. These numbers reflect our capacity and experience in delivering specialized care. Individual patient results will vary depending on clinical diagnosis, complexity, and inherent surgical risks. Results are not guaranteed. We adhere strictly to ethical guidelines prohibiting the suggestion of superior results or implied outcomes based on volume data.
Hemant Kalia, MD, MPH
Director, Advanced Neuromodulation
Advancing DRG-S: Clinical Work & Publications
Dr. Kalia’s expertise in Dorsal Root Ganglion stimulation places him at the forefront of treating complex, localized neuropathic pain. His clinical research continues to define best practices for difficult-to-treat conditions like CRPS.
📚 Selected Publications
- Neuromodulation Journal (2022): “Real-World Outcomes of Dorsal Root Ganglion Stimulation in the Management of Refractory Complex Regional Pain Syndrome (CRPS) Type I & II.”
- Pain Physician (2023): “Optimizing Lead Placement and Programming Strategies in DRG Stimulation for Chronic Groin and Pelvic Pain.”
- Textbook Contribution: Authored chapters on managing complications and preserving anatomical stability in advanced targeted neurostimulation techniques.
📊 National Scientific Posters
- North American Neuromodulation Society (NANS): “Comparative Analysis: DRG vs. Traditional SCS for Focal Lower Extremity Neuropathic Pain.” (Poster Presentation by Hemant Kalia, MD, MPH).
- American Society of Pain & Neuroscience (ASPN): “Long-Term Functional Restoration and Opioid Reduction in CRPS Patients Utilizing the Abbott Proclaim DRG System.”